Real-time enrollment status for this metastatic hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:02 PM UTC
| NCT Number | NCT06427941 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Hepatocellular Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 630 participants |
| Active Locations | 8 sites in the US |
| Sponsor | BeOne Medicines |
| Last Updated on CT.gov | September 16, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT06427941 is currently recruiting participants. This phase1 study for metastatic hepatocellular carcinoma is actively seeking new participants at 8 locations across the United States. The study is sponsored by BeOne Medicines. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06427941 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06427941 was last updated 3 weeks ago (September 16, 2026). HelloStudys verifies this status automatically.